|
SPATS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.81890000014751E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.580700E-04 |
| Normal-vs-Stage2 |
3.233900E-02 |
| Normal-vs-Stage3 |
3.358100E-03 |
| Normal-vs-Stage4 |
7.849100E-04 |
| Stage1-vs-Stage2 |
9.418200E-01 |
| Stage1-vs-Stage3 |
5.487200E-01 |
| Stage1-vs-Stage4 |
3.344200E-02 |
| Stage2-vs-Stage3 |
5.767600E-01 |
| Stage2-vs-Stage4 |
2.895800E-02 |
| Stage3-vs-Stage4 |
8.210300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.20999999994898E-06 |
| Normal-vs-AfricanAmerican |
2.05699999999975E-05 |
| Normal-vs-Asian |
1.883810E-01 |
| Caucasian-vs-AfricanAmerican |
4.441600E-01 |
| Caucasian-vs-Asian |
5.107400E-01 |
| AfricanAmerican-vs-Asian |
6.631400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.187790E-04 |
| Normal-vs-Female |
9.50279999134551E-09 |
| Male-vs-Female |
8.429700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.817200E-03 |
| Normal-vs-Extreme_Weight |
1.797730E-02 |
| Normal-vs-Obese |
4.05170000000732E-05 |
| Normal-vs-Extreme_Obese |
1.396850E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.792400E-01 |
| Normal_Weight-vs-Obese |
4.592000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.311600E-01 |
| Extreme_Weight-vs-Obese |
6.229600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.900400E-01 |
| Obese-vs-Extreme_Obese |
2.568600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.68799999999259E-05 |
| Normal-vs-Age(41-60Yrs) |
3.09609999860072E-08 |
| Normal-vs-Age(61-80Yrs) |
2.317900E-03 |
| Normal-vs-Age(81-100Yrs) |
4.705400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.131800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.117700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.215500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.601600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.187800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.912200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.55519999948062E-07 |
| Normal-VS-Type2 PRCC |
2.889800E-02 |
| Normal-VS-KIRP CIMP |
1.34690000264115E-08 |
| Normal-VS-Unclassified PRCC |
2.837500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.568200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.757800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.623400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.156700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.376400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.753600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.994000E-01 |
| Normal-vs-N1 |
2.594300E-04 |
| Normal-vs-N2 |
8.721900E-02 |
| N0-vs-N1 |
1.379150E-03 |
| N0-vs-N2 |
1.091760E-01 |
| N1-vs-N2 |
4.355000E-01 |
|
|
